The Role of Cysteine and Serine Proteases in Gastric Carcinogenesis and Their Prognostic Impact in Gastric Cancer
暂无分享,去创建一个
Z. Tulassay | F. Farinati | M. Plebani | R. Naccarato | P. Carraro | L. Herszényi | G. Roveroni | M. Paoli
[1] M. Rugge,et al. Cysteine and serine proteases in gastric cancer , 1995, Cancer.
[2] M. Rugge,et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1994, Gastroenterology.
[3] P. Quax,et al. Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. , 1994, Gastroenterology.
[4] M. Pignatelli,et al. Current concepts in metastasis. , 1994, Gut.
[5] K. Becker,et al. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. , 1994, Cancer research.
[6] P. Correa,et al. Phenotypic and genotypic events in gastric carcinogenesis. , 1994, Cancer research.
[7] M. Rugge,et al. p53 alteration in gastric precancerous lesions. , 1994, The American journal of pathology.
[8] S. Brem,et al. Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors. , 1994, Cancer research.
[9] F. Spyratos,et al. Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. , 1994, British Journal of Cancer.
[10] T. Terada,et al. Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions. , 1994, British Journal of Cancer.
[11] K. Ishikawa,et al. Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer , 1993, Japanese journal of cancer research : Gann.
[12] J. Reilly,et al. Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease. , 1993, Gut.
[13] F. Farinati,et al. Aspartic proteinases and gastrin in the diagnosis of gastric cancer and gastric precancerous changes , 1993 .
[14] W. Clarkston,et al. The use of GoLYTELY and Dulcolax in combination in outpatient colonoscopy. , 1993, Journal of clinical gastroenterology.
[15] M. Rugge,et al. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1993, Endoscopy.
[16] A. Aasen,et al. Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[17] H. Verspaget,et al. Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach. , 1993, Gut.
[18] T. Okuda,et al. Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer, and gastric cancer. , 1993, Journal of clinical gastroenterology.
[19] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[20] I. Hart,et al. Biology of tumour metastasis , 1992, The Lancet.
[21] M. Duffy,et al. Type‐1 plasminogen activator inhibitor in human breast carcinomas , 1992, International journal of cancer.
[22] H. Kawanishi,et al. Plasminogen activators in human gastric cancers: Correlation with DNA ploidy and immunohistochemical staining , 2007, International journal of cancer.
[23] P. Quax,et al. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis. , 1991, Gastroenterology.
[24] M. Rugge,et al. Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1991, Human pathology.
[25] K. Sheahan,et al. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas , 1991, International journal of cancer.
[26] M. Yasutomi,et al. Plasminogen activator inhibitor 1 in human carcinoma tissues , 1991, International journal of cancer.
[27] A. Price. The Sydney System: Histological division , 1991, Journal of gastroenterology and hepatology.
[28] M. Rugge,et al. Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study. , 1991, The Italian journal of gastroenterology.
[29] D. Nitti,et al. CA 50 Determination in body fluids: Can we screen patients at risk for gastric cancer? , 1991, International journal of cancer.
[30] T. Saku,et al. Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study. , 1990, Gut.
[31] M F Dixon,et al. High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. , 1990, Gut.
[32] S. Chung,et al. Protease activities in gastric cancer tissues. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[33] Bonnie F. Sloane. Cathepsin B and cystatins: evidence for a role in cancer progression. , 1990, Seminars in cancer biology.
[34] B. J. Unwin,et al. The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report. , 1990, Gut.
[35] Y. Yokota,et al. Purification and properties of cathepsin B from sea urchin eggs , 1990 .
[36] M. Watanabe,et al. Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings. , 1989, Biochemical medicine and metabolic biology.
[37] M. Rugge,et al. Follow-up in gastric dysplasia patients. , 1989, The American journal of surgical pathology.
[38] P. Correa,et al. A human model of gastric carcinogenesis. , 1988, Cancer research.
[39] Y. Takada,et al. The urokinase type of plasminogen activator in cancer of digestive tracts. , 1988, Thrombosis research.
[40] D. Nitti,et al. CA 19-9 determination in gastric justice: Role in identifying gastric cancer and high risk patients , 1988 .
[41] P. Correa. Chronic gastritis: a clinico-pathological classification. , 1988, The American journal of gastroenterology.
[42] G. Markus. The relevance of plasminogen activators to neoplastic growth. A review of recent literature. , 1988, Enzyme.
[43] D. Rifkin,et al. Cell-associated plasminogen activation: regulation and physiological functions. , 1988, Annual review of cell biology.
[44] H. Verspaget,et al. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas. , 1987, Cancer research.
[45] K. Huber,et al. Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas , 1987 .
[46] C. Kluft,et al. Plasminogen activator inhibitors. , 1987, Blood.
[47] A. Barrett,et al. Elastinolytic activity of human cathepsin L. , 1986, The Biochemical journal.
[48] A. Cuschieri,et al. Proteinase‐like peptidase activities in malignant and non‐malignant gastric tissue , 1985, The British journal of surgery.
[49] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[50] N. Muñoz,et al. Gastric dysplasia. Significance and pathologic criteria , 1984, Cancer.
[51] A. Piccoli,et al. Carcinoembryonic antigen in gastric juice collected during endoscopy. Value in detecting high‐risk patients and gastric cancer , 1983, Cancer.
[52] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[53] P. Sipponen,et al. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample , 1983, Cancer.
[54] J. Rotter,et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. , 1982, Gastroenterology.
[55] L. Sobin,et al. Precancerous conditions and epithelial dysplasia in the stomach. , 1980, Journal of clinical pathology.
[56] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.